Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Open in API
Filings indexed 553 across all filing types
Latest filing 2023-12-04 Capital/Financing Update
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득(제36회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from HLB regarding the acquisition of convertible bonds before maturity (Put Option exercise). This type of disclosure relates to changes in the company's capital structure and debt obligations. Among the provided categories, 'CAP' (Capital/Financing Update) is the most appropriate classification as it covers updates on financing activities and capital structure changes, including the redemption or repurchase of debt instruments like convertible bonds.
2023-12-04 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice regarding the convocation of a shareholder meeting (Extraordinary General Meeting) for HLB. It details the date, location, and agenda items (such as the delisting from KOSDAQ and transfer to KOSPI). This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of the meeting and the items to be voted upon.
2023-11-21 Korean
[기재정정]상장폐지승인을위한의안상정결정
Delisting Announcement Classification · 1% confidence The document is a regulatory filing regarding a decision to propose delisting from the KOSDAQ market and listing on the KOSPI market, which requires shareholder approval at an extraordinary general meeting. While it mentions delisting, it is a corporate action announcement regarding a change in listing venue rather than a final delisting notice. Given the specific nature of the filing (a regulatory disclosure of a board decision regarding listing status), it fits best under the 'Regulatory Filings' category as it is a formal disclosure of a corporate event.
2023-11-21 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to request shareholder proxies for upcoming general meetings. It details the purpose of the solicitation, the proxy agent, the voting methods (electronic voting/proxy), and the agenda items for the Extraordinary General Meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2023-11-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Extraordinary General Meeting' (주주총회소집공고) for HLB Co., Ltd. It contains the meeting agenda, date, location, and detailed management reference materials (such as director activity reports and financial transaction details) required for shareholders to make informed voting decisions. This document is a standard proxy statement/information circular provided to shareholders prior to a meeting.
2023-11-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by HLB Co., Ltd. This type of filing is a standard regulatory requirement in South Korea for directors and major shareholders to disclose their shareholdings and changes therein. This falls under the category of 'Director's Dealing' (DIRS), as it reports the personal share ownership and changes for a specific executive (Nam Yun-jei).
2023-11-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.